Showing posts with label Cardiovascular Diseases Therapeutics Market. Show all posts
Showing posts with label Cardiovascular Diseases Therapeutics Market. Show all posts

Monday 25 November 2013

Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

New Market Research Report Added in MarketResearchReports.Biz Reports Database: Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use
  
, "Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use", which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.


Scope

  • Disease overview and treatment usage patterns
  • Market size and forecast for heart failure, MI and ACS in APAC market from 2012 to 2019
  • Major marketed products for the indications types covered
  • In-depth pipeline analysis for heart failure, MI and ACS
  • Key drivers and restraints that have had and are expected to have a significant impact upon the market
  • Key licensing and co-development agreements in the cardiovascular market

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179627

Reasons to Buy

The report will enhance your decision-making capability by allowing you to:

  • Align your product portfolio to the markets with high growth potential
  • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
  • Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the cardiovascular market
  • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Therapeutic Landscape
3.1 Heart Failure
3.1.1 Symptoms
3.1.2 Etiology
3.1.3 Pathophysiology
3.1.4 Co-morbidities and Complications
3.1.5 Diagnosis
3.1.6 Classification
3.1.7 Prognosis and Disease Staging
3.1.8 Treatment Options
3.2 Myocardial Infarction
3.2.1 Symptoms
3.2.2 Etiology
3.2.3 Pathophysiology
3.2.4 Co-morbidities and Complications
3.2.5 Diagnosis
3.2.6 Classification
3.2.7 Treatment Options
3.3 Acute Coronary Syndrome
3.3.1 Symptoms
3.3.2 Etiology
3.3.3 Pathophysiology
3.3.4 Diagnosis
3.3.5 Treatment Options

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/179627

4 Marketed Products
4.1 Heart Failure
4.2 Myocardial Infarction
4.3 Acute Coronary Syndrome
4.4 Key Marketed Products
4.4.1 Arixtra (GlaxoSmithKline plc)
4.4.2 Brilinta (AstraZeneca plc)
4.4.3 Crestor (AstraZeneca plc)
4.4.4 Diovan (valsartan) and Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)
4.4.5 Atacand (candesartan)
4.4.6 Lipitor (Atorvastatin Tablets)
4.4.7 Clopidogrel bisulfate
4.4.8 Angiomax (bivaluridin)
4.4.9 Lovenox (enoxaparin sodium injection)
4.4.10 Norvasc (amlodipine)
4.4.11 Coreg
4.4.12 Ivabradine (Les Laboratoires Servier SAS)
4.4.13 Toprol-XL

5 Pipeline Analysis
5.1 Heart Failure Pipeline
5.1.1 Overall Pipeline
5.1.2 Pipeline Analysis by Molecule Type
5.1.3 Pipeline Analysis by Mechanism of Action
5.2 Myocardial Infarction Pipeline
5.2.1 Overall Pipeline
5.2.2 Pipeline Analysis by Molecule Type
5.2.3 Pipeline Analysis by Mechanism of Action

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Blog: http://marketresearchreportsbiz.blogspot.in/